986 related articles for article (PubMed ID: 24934489)
1. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
3. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
4. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
[TBL] [Abstract][Full Text] [Related]
5. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
6. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
[TBL] [Abstract][Full Text] [Related]
7. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
8. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
9. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
10. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
11. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist.
Lyttle Schumacher BM; Mersereau JE; Steiner AZ
Fertil Steril; 2018 Apr; 109(4):633-637. PubMed ID: 29605403
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
[TBL] [Abstract][Full Text] [Related]
13. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
14. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
[TBL] [Abstract][Full Text] [Related]
15. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
[TBL] [Abstract][Full Text] [Related]
16. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
17. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
18. Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.
Orvieto R; Volodarsky M; Hod E; Homburg R; Rabinson J; Zohav E; Anteby EY; Meltcer S
Gynecol Endocrinol; 2007; 23(8):494-6. PubMed ID: 17852411
[TBL] [Abstract][Full Text] [Related]
19. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
20. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
Orvieto R; Rabinson J; Meltcer S; Gemer O; Anteby EY; Zohav E
Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]